je.st
news
Gilead Submits New Drug Application to Japan's Pharmaceutical and...
2014-06-27 19:44:59| Biotech - Topix.net
Gilead Sciences, Inc. today announced that the company has submitted a New Drug Application to Japan's Pharmaceutical and Medical Devices Agency for approval of sofosbuvir, a once-daily nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C virus infection.
Tags: application
drug
pharmaceutical
submits
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||